287 related articles for article (PubMed ID: 16220048)
1. Irritable bowel syndrome and probiotics: from rationale to clinical use.
Verdu EF; Collins SM
Curr Opin Gastroenterol; 2005 Nov; 21(6):697-701. PubMed ID: 16220048
[TBL] [Abstract][Full Text] [Related]
2. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
Camilleri M
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
[TBL] [Abstract][Full Text] [Related]
3. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.
Quigley EM; Flourie B
Neurogastroenterol Motil; 2007 Mar; 19(3):166-72. PubMed ID: 17300285
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
Didari T; Mozaffari S; Nikfar S; Abdollahi M
World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
[TBL] [Abstract][Full Text] [Related]
5. THE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a review.
Moraes-Filho JP; Quigley EM
Arq Gastroenterol; 2015 Dec; 52(4):331-8. PubMed ID: 26840477
[TBL] [Abstract][Full Text] [Related]
6. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.
Principi N; Cozzali R; Farinelli E; Brusaferro A; Esposito S
J Infect; 2018 Feb; 76(2):111-120. PubMed ID: 29291933
[TBL] [Abstract][Full Text] [Related]
7. Review article: probiotics and prebiotics in irritable bowel syndrome.
Spiller R
Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of probiotics in IBS.
Quigley EM
J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S85-90. PubMed ID: 18542036
[TBL] [Abstract][Full Text] [Related]
9. Probiotics in Irritable Bowel Syndrome: The Science and the Evidence.
Quigley EM
J Clin Gastroenterol; 2015; 49 Suppl 1():S60-4. PubMed ID: 26447967
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935
[TBL] [Abstract][Full Text] [Related]
11. Systematic review: Complementary and alternative medicine in the irritable bowel syndrome.
Hussain Z; Quigley EM
Aliment Pharmacol Ther; 2006 Feb; 23(4):465-71. PubMed ID: 16441466
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.
Nikfar S; Rahimi R; Rahimi F; Derakhshani S; Abdollahi M
Dis Colon Rectum; 2008 Dec; 51(12):1775-80. PubMed ID: 18465170
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
14. Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review.
Dale HF; Rasmussen SH; Asiller ÖÖ; Lied GA
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31480656
[TBL] [Abstract][Full Text] [Related]
15. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
16. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
[TBL] [Abstract][Full Text] [Related]
17. Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.
Brenner DM; Chey WD
Rev Gastroenterol Disord; 2009; 9(1):7-15. PubMed ID: 19367213
[TBL] [Abstract][Full Text] [Related]
18. [Probiotics as therapeutic agents in irritable bowel syndrome].
Krammer HJ; Schlieger F; Harder H; Franke A; Singer MV
Z Gastroenterol; 2005 May; 43(5):467-71. PubMed ID: 15871070
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial.
Han K; Wang J; Seo JG; Kim H
J Gastroenterol; 2017 Apr; 52(4):432-443. PubMed ID: 27178566
[TBL] [Abstract][Full Text] [Related]
20. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
